231 related articles for article (PubMed ID: 30462889)
1. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
[TBL] [Abstract][Full Text] [Related]
2. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
[TBL] [Abstract][Full Text] [Related]
3. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
Shui B; Xia W; Wen C; Ding X
J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132
[TBL] [Abstract][Full Text] [Related]
4. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.
Ichinose K; Juang YT; Crispín JC; Kis-Toth K; Tsokos GC
Arthritis Rheum; 2011 Feb; 63(2):523-9. PubMed ID: 20954187
[TBL] [Abstract][Full Text] [Related]
5. Comparative transcriptome analysis reveals a potential role for CaMK4 in γδT17 cells from systemic lupus erythematosus patients with lupus nephritis.
Du B; Fan X; Lei F; Zhang S; Li G; Xi X
Int Immunopharmacol; 2020 Mar; 80():106139. PubMed ID: 31978801
[TBL] [Abstract][Full Text] [Related]
6. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Otomo K; Koga T; Mizui M; Yoshida N; Kriegel C; Bickerton S; Fahmy TM; Tsokos GC
J Immunol; 2015 Dec; 195(12):5533-7. PubMed ID: 26561550
[TBL] [Abstract][Full Text] [Related]
7. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
[TBL] [Abstract][Full Text] [Related]
8. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
9. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
Koga T; Hedrich CM; Mizui M; Yoshida N; Otomo K; Lieberman LA; Rauen T; Crispín JC; Tsokos GC
J Clin Invest; 2014 May; 124(5):2234-45. PubMed ID: 24667640
[TBL] [Abstract][Full Text] [Related]
10. The role of CaMK4 in immune responses.
Koga T; Kawakami A
Mod Rheumatol; 2018 Mar; 28(2):211-214. PubMed ID: 29252071
[TBL] [Abstract][Full Text] [Related]
11. Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus.
Koga T; Ichinose K; Mizui M; Crispín JC; Tsokos GC
J Immunol; 2012 Oct; 189(7):3490-6. PubMed ID: 22942433
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation.
Kono M; Maeda K; Stocton-Gavanescu I; Pan W; Umeda M; Katsuyama E; Burbano C; Orite SYK; Vukelic M; Tsokos MG; Yoshida N; Tsokos GC
JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31217348
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcium/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis.
Koga T; Umeda M; Yoshida N; Satyam A; Jha M; Scherlinger M; Bhargava R; Tsokos MG; Sato T; Furukawa K; Endo Y; Fukui S; Iwamoto N; Abiru N; Okita M; Ito M; Kawakami A; Tsokos GC
Rheumatology (Oxford); 2023 Feb; 62(2):861-871. PubMed ID: 35781320
[TBL] [Abstract][Full Text] [Related]
14. CaMK4 promotes abortion-related Th17 cell imbalance by activating AKT/mTOR signaling pathway.
Chang S; Yin T; He F; Ding J; Shang Y; Yang J
Am J Reprod Immunol; 2020 Dec; 84(6):e13315. PubMed ID: 32738170
[TBL] [Abstract][Full Text] [Related]
15. Calcium/Calmodulin-Dependent Kinase IV Facilitates the Recruitment of Interleukin-17-Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell-Driven Inflammatory Diseases.
Koga T; Otomo K; Mizui M; Yoshida N; Umeda M; Ichinose K; Kawakami A; Tsokos GC
Arthritis Rheumatol; 2016 Aug; 68(8):1981-8. PubMed ID: 26945541
[TBL] [Abstract][Full Text] [Related]
16. Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.
Cheng T; Ding S; Liu S; Li X; Tang X; Sun L
Front Immunol; 2021; 12():668760. PubMed ID: 34093566
[TBL] [Abstract][Full Text] [Related]
17. Understanding the pathogenic significance of altered calcium-calmodulin signaling in T cells in autoimmune diseases.
Koga T
Clin Immunol; 2024 May; 262():110177. PubMed ID: 38460894
[TBL] [Abstract][Full Text] [Related]
18. Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice.
Lin M; Huang L; Huang J; Yu J; Yang X; Yang J
J Autoimmun; 2024 May; 145():103198. PubMed ID: 38428341
[TBL] [Abstract][Full Text] [Related]
19. Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.
Ichinose K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Arima K; Nakamura H; Obata Y; Yamamoto K; Origuchi T; Nishino T; Kawakami A; Tsokos GC
Arthritis Rheumatol; 2016 Apr; 68(4):944-52. PubMed ID: 26636664
[TBL] [Abstract][Full Text] [Related]
20. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.
Yang J; Chu Y; Yang X; Gao D; Zhu L; Yang X; Wan L; Li M
Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
